×
Nanovibronix Price to Free Cash Flow Ratio 2014-2024 | NAOV
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
Nanovibronix price to free cash flow ratio from 2014 to 2024. Price to free cash flow ratio can be defined as
View More
Nanovibronix Price to Free Cash Flow Ratio 2014-2024 | NAOV
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
Nanovibronix price to free cash flow ratio from 2014 to 2024. Price to free cash flow ratio can be defined as
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$214.1B
Intuitive Surgical (ISRG)
$183.6B
Alcon (ALC)
$45.1B
IQVIA Holdings (IQV)
$40.2B
Edwards Lifesciences (EW)
$39.6B
IDEXX Laboratories (IDXX)
$34.7B
DexCom (DXCM)
$26.8B
Waters (WAT)
$23B
STERIS (STE)
$22.4B
SONOVA HOLDING (SONVY)
$21.9B
Hologic (HOLX)
$18.7B
Fresenius Medical Care AG KGaA (FMS)
$12.4B
Sysmex ADR (SSMXY)
$11.9B
Globus Medical (GMED)
$11.2B
Teleflex (TFX)
$9.4B
Penumbra (PEN)
$9B
Masimo (MASI)
$8.9B
Glaukos (GKOS)
$7.8B
PROCEPT BioRobotics (PRCT)
$5.1B
Integer Holdings (ITGR)
$4.5B
Inari Medical (NARI)
$3.1B
TransMedics (TMDX)
$2.9B
LivaNova (LIVN)
$2.8B
Veracyte (VCYT)
$2.8B
Nihon Kohden (NHNKY)
$2.5B
Tandem Diabetes Care (TNDM)
$2.2B
Elekta AB (EKTAY)
$2.2B
Integra LifeSciences Holdings (IART)
$2.1B
RxSight (RXST)
$2B
Alphatec Holdings (ATEC)
$1.3B